NLX-101 for the Treatment of Rett Syndrome
community download

NLX-101 for the Treatment of Rett Syndrome

information we require

please check before submitting



Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Mark Varney of Neurolixis  joined us at World Orphan Drug Congress USA 2015 to present about ' NLX-101 for the Treatment of Rett Syndrome'.
 

Download the presentation now to learn about:

  • Rett Syndrome: Key Facts
  • Pleiotropy in Rett Syndrome

  • NLX-101: A selective 5-HT 1A  receptor "biased agonist"  

...and much more!
 
Get your copy here! 
 
To find out more about  NLX-101 as a treatment of Rett Syndrome , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.